21 completed, 3 terminated, 3 unknown. 27 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 27 | Completed 21, Terminated 3, Unknown 3 |
| Phase 2 | 5 | Completed 3, Terminated 1, Unknown 1 |
Follow Renal Failure: new trials by email Literature Review of Renal Failure trials Research Report on Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Low Protein Diet Supplemented With Ketoanalogues Supplementation on Uremic Toxins Production keto-analogs - Renal Failure | Phase 3 | Unknown | Hospices Civils de Lyon | 50 | 2019-11-12 | 2021-07-09 |
| Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Human Acellular Vessel (HAV), Arteriovenous fistula (AVF), Hemodialysis - Renal Failure, End Stage Renal Disease | Phase 3 | Completed | Humacyte, Inc. | 242 | 2017-09-29 | 2025-11-20 |
| Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis Human Acellular Vessel (HAV), ePTFE graft - Renal Failure, End Stage Renal Disease | Phase 3 | Completed | Humacyte, Inc. | 355 | 2016-05-24 | 2026-08-19 |
| HBV Vaccine in Renal Failure Patients Intradermal HBVv with imiquimod, Intradermal HBVv with aqueous cream, Intramuscular HBVv with aqueous cream - Renal Failure | Phase 2 / Phase 3 | Completed | The University of Hong Kong | 94 | 2016-01-01 | 2019-10-22 |
| Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure Ketoacids, Placebo - Renal Failure | Phase 3 | Completed | University of Chile | 147 | 2015-09-01 | 2019-01-16 |
| Pharmacokinetic Comparison Of All FK-506 Formulations Prograf vs Envarsus XR vs Astagraf XL, Prograf vs Astagraf XL vs Envarsus XR - Renal Failure | Phase 3 | Completed | Veloxis Pharmaceuticals | 32 | 2015-01-01 | 2016-01-18 |
| Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Advagraf - Renal Failure, Renal Insufficiency | Phase 3 | Unknown | Technische Universität Dresden | 400 | 2014-09-01 | 2022-08-03 |
| Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure Daptomycin - Renal Failure, Critical Care | Phase 3 | Completed | Poitiers University Hospital | 2014-03-01 | 2016-10-11 | |
| Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily. LCP-Tacro, Tacrolimus -IR - Renal Failure | Phase 3 | Completed | Veloxis Pharmaceuticals | 50 | 2013-11-01 | 2018-06-06 |
| A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis ferric citrate - End Stage Renal Disease, Kidney Failure | Phase 3 | Completed | Keryx Biopharmaceuticals | 168 | 2012-08-01 | 2016-07-13 |
| Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients Remote ischemic preconditioning stimulus, control - Death, Stroke | Phase 3 | Completed | Queen's University | 429 | 2012-02-01 | 2016-02-05 |
| Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO) Prograf, LCP-Tacro - Renal Failure, Tremors | Phase 3 | Completed | Veloxis Pharmaceuticals | 44 | 2011-12-01 | 2015-10-01 |
| Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx Prograf (tacrolimus), LCP-Tacro - Renal Failure | Phase 3 | Completed | Veloxis Pharmaceuticals | 543 | 2010-09-01 | 2016-05-18 |
| Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill atorvastatin 80 mg per os daily, placebo - Myocardial Infarction, Stroke | Phase 2 / Phase 3 | Completed | University of Alberta | 100 | 2009-04-01 | 2011-12-16 |
| Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily LCP-Tacro, Prograf - Renal Failure | Phase 3 | Completed | Veloxis Pharmaceuticals | 326 | 2008-12-01 | 2015-09-10 |
| Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitis Human Albumin - Cirrhosis, Sepsis | Phase 3 | Terminated | Centre Hospitalier Universitaire de Besancon | 193 | 2008-12-01 | 2014-05-13 |
| GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface, Percutaneous Transluminal Angioplasty - Renal Failure, Hemodialysis | Phase 3 | Completed | W.L.Gore & Associates | 293 | 2008-09-01 | 2014-10-21 |
| Nephrogenic Systemic Fibrosis With Gadollinum gadollinum - Nephrogenic Systemic Fibrosis, Renal Failure | Phase 2 / Phase 3 | Unknown | Imam Khomeini Hospital | 200 | 2008-07-01 | 2012-06-22 |
| Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure Heme Iron Polypeptide (Proferrin), Iron sucrose (Venofer) - Anemia, Renal Failure | Phase 2 / Phase 3 | Completed | Ottawa Hospital Research Institute | 55 | 2007-05-01 | 2016-05-10 |
| COOL RCN: Cooling to Prevent Radiocontrast Nephropathy Reprieve Endovascular Temperature Therapy System - Renal Failure, Kidney Failure | Phase 2 / Phase 3 | Terminated | Radiant Medical | 400 | 2006-03-01 | 2008-08-05 |
Showing 20 of 27. Sign in to see all of them.
Renal Insufficiency (27) · Kidney Failure, Chronic (5) · Critical Illness (2) · Myocardial Infarction (2) · Renal Insufficiency, Chronic (2) · Stroke (2) · Anemia (1) · Cardiac Output, Low (1) · Death (1) · Fibrosis (1) · Heart Failure (1) · Hyperphosphatemia (1) · Kidney Diseases (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1)
Female Urogenital Diseases (27) · Female Urogenital Diseases and Pregnancy Complications (27) · Male Urogenital Diseases (27) · Urogenital Diseases (27) · Urologic Diseases (27) · Kidney Diseases (26) · Pathological Conditions, Signs and Symptoms (12) · Pathologic Processes (11) · Disease Attributes (9) · Chronic Disease (7) · Renal Insufficiency, Chronic (5) · Cardiovascular Diseases (4) · Heart Diseases (3) · Nervous System Diseases (3) · Vascular Diseases (3)
Tacrolimus (5) · Angioplasty (1) · Arteriovenous Shunt, Surgical (1) · Atorvastatin (1) · Daptomycin (1) · Dexamethasone (1) · Drug Therapy (1) · Ferric Oxide, Saccharated (1) · Furosemide (1) · Imiquimod (1) · Keto Acids (1) · Plasmapheresis (1) · Renal Dialysis (1) · Rosuvastatin Calcium (1) · Serum Albumin, Human (1)
Veloxis Pharmaceuticals (5) · Humacyte, Inc. (2) · AstraZeneca (1) · Centre Hospitalier Universitaire de Besancon (1) · Frisius Medisch Centrum (1) · Hospices Civils de Lyon (1) · Hospital Sao Lucas da PUCRS (1) · Imam Khomeini Hospital (1) · Keryx Biopharmaceuticals (1) · Ottawa Hospital Research Institute (1) · Poitiers University Hospital (1) · Queen's University (1) · Radiant Medical (1) · Technische Universität Dresden (1) · The University of Hong Kong (1)
United States (12) · France (5) · Canada (4) · Germany (4) · Brazil (3) · Poland (3) · United Kingdom (3) · Australia (2) · Italy (2) · Mexico (2) · Netherlands (2) · Puerto Rico (2) · South Korea (2) · Sweden (2) · Switzerland (2)
Shamik Parikh, MD (2) · Alan Glicklich (1) · Alan Glicklich, MD (1) · Christian Hugo, MD, PhD (1) · Daniel Bunout, MD (1) · Darrin Payne, MD (1) · Deborah Zimmerman, MD (1) · Gill Gaskin, MD (1) · Gregg Stone, MD (1) · Ivan FN Hung, MD FRCP (1) · Julia B Lewis, MD (1) · Karin T Kirchhoff, PhD (1) · Leslie Callahan, RN (1)
PMID 17848650, PMID 19114909, PMID 19272686, PMID 19332456, PMID 19628319, PMID 20584291, PMID 20649686, PMID 23514036, PMID 25463545, PMID 27340950, PMID 29162334, PMID 29462506, PMID 30717951, PMID 32556176, PMID 36472416, PMID 37662589, PMID 39878152, PMID 42613284
2015 (1)